Skip to main content
DTIL
NASDAQ Life Sciences

Precision BioSciences Posts 28-Cent Loss, Beats Estimates by Wide Margin

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$7.33
Mkt Cap
$191.831M
52W Low
$3.53
52W High
$9.62
52W Position info
108% above low
Off High info
24% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

DTIL has more than doubled off its 52-week low of $3.53.

Summary

Precision BioSciences reported a Q3 adjusted loss of 28 cents per share, far narrower than the 85-cent loss five analysts expected and a big improvement from the $1.84 loss a year earlier. Revenue was zero versus the $1.10M analysts modeled, so the beat is cost-driven, not commercial. The $7.59M quarterly net loss was flattered by a $12.7M non-cash warrant remeasurement gain disclosed in the 10-Q filed this morning, which also showed $108.0M of cash and runway guided through 2028. Shares are up 67.1% year to date and 11.0% this quarter heading into the print, and the Street still carries a strong buy consensus with a $20 median target. The zero-revenue line keeps the story about cash burn and the PBGENE-DMD Phase 1/2 program, where the first patient was dosed in August.

At the time of this announcement, DTIL was trading at $7.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $191.8M. The 52-week trading range was $3.53 to $9.62. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

DTIL - Latest Insights

DTIL
Nov 05, 2026, 7:10 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $7.73
Real-time Price: $6.99 info
Change: -$0.740 (-10%) info
Market Cap: $195.271M info
DTIL
Nov 05, 2026, 7:07 AM EST
Filing Type: FWP
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $6.99 info
Change: -$1.51 (-18%) info
Market Cap: $195.271M info
DTIL
Nov 05, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $8.39
Real-time Price: $6.99 info
Change: -$1.40 (-17%) info
Market Cap: $195.271M info
DTIL
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $8.57
Real-time Price: $6.99 info
Change: -$1.58 (-18%) info
Market Cap: $195.271M info
DTIL
Nov 05, 2026, 7:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $8.39
Real-time Price: $6.99 info
Change: -$1.40 (-17%) info
Market Cap: $195.271M info